The current study is directed at identifying compounds that have biological activity in the less studied oil fraction of Curcuma longa (turmeric) to treat pancreatic cancer, which has no good treatment options. Fractional distillation and chromatographic separation of turmeric oil (TO) gave column fractions (CF) having biological activity against the PANC-1 pancreatic cancer cell line, with an EC 50 in the range of 23 to 33 g/mL. These fractions were analyzed by NMR and GCMS and found to contain the sesquiterpenes, ar-curcumene, 7-epi-zingiberene, -sesquiphellandrene, curlone, -turmerone, -turmerone and ar-turmerone. The ability of TO components to induce cell death was independent of caspase activity. Potency was higher at lower cell density and was reduced by increasing serum concentration, the latter indicating serum binding of active components.
Turmeric is known as the "golden spice" as well as the "spice of life". For thousands of years of documented history, it has been used as a medicinal plant in Ayurvedic medicine and in many socioreligious practices [1] . Turmeric root has several active ingredients that are responsible for its varied medicinal properties. Among the identified compounds, curcumin is the best studied. However, it has some disadvantages because of its poor bioavailability. The less studied essential oil constitutes about 3-6% of the dry weight of the rhizomes and this volatile fraction contains mainly sesquiterpenes, including ar-turmerone [2, 3] . Our research has identified and characterized sesquiterpenes in the fractions of turmeric oil and we have shown that they have anticancer properties against breast, pancreatic and prostate cancer [4] . Pancreatic cancer is the fourth leading cause of death in the United States with an overall survival rate of <5% [5] . Since there are not many treatment options for pancreatic cancer, it is important to identify the structural features of these compounds that inhibit the cell proliferation to generate new therapies. The low toxicity of these compounds helps their use for cancer prevention and treatment. We used Curcuma longa L. (Alleppey finger variety) that was cultivated specifically for the study. Turmeric oil was obtained by n-hexane extraction of turmeric powder. This was purified by high vacuum distillations and by medium pressure liquid chromatography (MPLC). In this paper we report the components of the biologically active fractions and their in vitro cell culture activity.
Turmeric powder was extracted with n-hexane and the crude extract was distilled under high vacuum to obtain a fraction that distilled at 108-122 o C. This was further purified by silica gel column chromatography. One fraction, CF-1, was further purified to give CF-5. Another fraction, CF-3, was analyzed by GC-MS and 1 H NMR and determined to be a mixture of β-turmerone/curlone (53%), α-turmerone (36%), ar-turmerone (4%), and an unidentified component (7%) by comparison with published NMR data [6] . Percentages were calculated from relative integration values of the resolved peaks of each as a function of the whole sample including the unidentified components. See supplemental information for the spectra and NMR shifts for each component listed beside the literature values. Overlays of the original spectrum and the 1D TOCSY showed the presence of -turmerone. CF-4 corresponds to ar-turmerone by GC-MS and NMR analysis. CF-5 was analyzed by 1 H and 1D TOCSY NMR and determined to be a mixture of -sesquiphellandrene (50.3%), 7-epi-zingiberene (30.7%) and ar-curcumene (19%) by comparison with published NMR data [7, 8] . Percentages were calculated from relative integration values of the resolved peaks of each of the 3 major components.
Cytotoxic activity of the TO fractions against PANC-1 cells:
As a reference, the EC 50 of curcumin in the PANC-1 cell line was determined and found to be 23.4 μg/mL (63.5 µM, data not shown). The concentrations in this study are represented in "μg/mL" and not "µM" because each fraction could have been representative of a single compound or a combination of multiple compounds. The effect of the TO fractions was determined in dose response curves. The curves are shown in Figure 1 and the data summarized in Table  1 . CF-1, CF-2, CF-3 and CF-5, all demonstrated biological activity at concentrations well below 110.52 μg/mL, equivalent to 300 μM curcumin. The most potent TO component was CF-5, with an EC 50 of 23.3 μg/mL. The least active fraction was CF-4, identified to be ar-turmerone, which induced only about 50% cell death at the highest concentration tested of 110.5 μg/mL. In comparison, the dose curve for unfractionated turmeric oil just reached 100% cytotoxicity at 110.5 μg/mL, yielding an EC 50 of ~73.7 μg/mL (data not shown).
Effect of cell density on TO fraction activity:
The potency of the TO fractions appeared to vary with the number of cells that were NPC Natural Product Communications PANC-1 cells were plated at 5,000 cells per well, treated with TO fractions for 24 h, and assayed with MTT, as described in the legend of Figure 2 . EC 50 values are the average of three independent trials, with each data point the average of five replicate wells. Values were determined using GraphPad Prism 5.1. * A true EC 50 for CF-4 was not determinable using GraphPad Prism since less than 100% cytotoxicity was observed at 110.5 µg/mL (approximately 50% cytotoxicity was observed at 110.5 µg/mL). Cells were plated at 5,000 cells per well and cytotoxicity measured using the MTT assay after treatment for 24 hours. Graphs show the cytotoxicity of these TO fractions over a concentration range of 3.7-110.5 μg/mL. Each graph represents the average of three independent experiments, with each point the average of five replicate wells. Error bars represent the experimental SEM. EC 50 values are shown in Table 1 . Data for CF-4 is not shown.
3a
3b Figure 2 : Effect of plating density on the potency of a) CF-2 and b) CF-3 on PANC-1 cells. PANC-1 cells were seeded at a density of either 5,000 or 15,000 cells per well. Cells were treated for 24 hours with concentrations of CF-2 and CF-3 over the range of 3.7-110.5 μg/mL. Cytotoxicity was determined using the MTT assay. Each graph represents the average of three independent experiments, with each point the average of five replicate wells. Error bars represent the experimental SEM. EC 50 values are shown in Table 2 . PANC-1 cells were seeded in 96-well culture plates at either 5,000 or 15,000 cells/well and incubated with increasing concentration of CF-2 and CF-3, as described in the legend of Figure 3 . After 24 h, cell viability was quantified using the MTT assay. EC 50 values represent the average of three independent experiments performed in five replicate wells, ± SEM.
plated. In experiments that tested the effect of cell density on the potency of the fractions, we determined the EC 50 values using 5,000 to 15,000 cells per well. The dose curves for CF-2 and CF-3 were each significantly shifted to the right at the higher cell density (Figure 2 , Table 2 ). The potency was reduced by the same magnitude for each TO fraction. Thus increased cell crowding reduces potency. PANC-1 cells were plated at 5,000 cells per well. After a 24 hour period to allow attachment, the normal media was exchanged with media containing 1% FBS, 3% FBS, and 10% FBS (normal media) and treated with increasing concentrations of CF-3 over a range of 3.7-110. 5 
Effect of serum concentration on the potency of TO fractions:
Drugs that are lipid-soluble are often insoluble in the bloodstream and have to be transported with proteins such as albumin. The concentration of such proteins would alter the equilibrium of the free vs. bound state of the drug since only the free drug can act upon target cells and exert its biological effects. Many compounds in turmeric oil have low aqueous solubility; for this reason, we determined whether the concentration of FBS would affect the potency of the fractions. We used CF-3, for the serum studies in PANC-1 cells. The 24 hour dose curves for CF-3 were determined at 1, 3, and 10% FBS. Compared with the normal condition of 10% FBS, the EC 50 values shifted markedly to the left as the serum concentration was lowered, yielding EC 50 values of 30.1, 17.5, and 8.6 μg/mL for 10%, 3%, and 1% (v/v) serum, respectively (Figure 3 ). This indicates binding of the TO components to serum. 
CF-2 and CF-3 induce cell death in a largely caspaseindependent manner:
Curcumin has been shown to induce apoptosis via both caspase-dependent and caspase-independent mechanisms in many cell models [9] . To determine if these turmeric oil fractions are activating caspase pathways critical for induction of cell death, we used Z-VAD-FMK, a cell-permeant, pan-caspase inhibitor to look for changes in the potency of CF fractions with or without inhibitor treatment. A decrease in potency of the fractions with Z-VAD-FMK would suggest that they are behaving in a largely caspase-dependent manner. Z-VAD-FMK (50 μM) exhibited negligible cytotoxicity alone and had no effect on the ability of either CF-2 or CF-3 to induce cell death at a concentration of 29.47 μg/mL (Figure 4 ). Therefore, caspase activation does not appear to play a role in the cytotoxic activity of CF-2 and CF-3.
We have previously shown that turmeric oil fractions have in vitro inhibitory activity on breast, pancreatic and prostate cancer cell lines [4] . The goal of this study is a more detailed fractionation of turmeric oil and to identify the fractions with cytotoxic effects Cytotoxic turmeric oil components Natural Product Communications Vol. 8 (6) 2013 813 against a pancreatic cancer cell line. The crude turmeric oil fraction was obtained and its in vitro anti-cancer activity against pancreatic cancer was determined. Fractional distillation followed by column chromatography gave the fractions for biological studies. The activity was increased considerably for CF-1 when it was further purified to obtain CF-5, probably by concentrating the active components in the fraction. The mixtures were grouped into three distinct groups. The first fraction contained mainly sesquiterpene hydrocarbons, the second sesquiterpene ketones, and the third containing aromatic, ar-turmerone. The hydrocarbon fraction was the most active (EC 50 23.3 g/mL) while the fractions containing compounds with a keto functional group on the side chain of sesquiterpenes also showed considerable activity. ar-Turmerone, an aromatic sesquiterpene with a keto functional group on the side chain had reduced activity. From this, we can conclude that the cyclohexane group increases cytotoxicity to PANC-1 cells and the hydrophobicity of the side chain influences activity. Further purification of each individual compound is needed to identify the structural features necessary for the in vitro anticancer activity.
Decreased sensitivity to TO fractions was observed when the plating density was increased from 5,000 to 15,000 cells/well. This seems to suggest something about the mechanism by which compounds in TO are inducing cell death, that is, they may be targeting cells that are rapidly dividing [10] . At the higher cell density, and with the rapid doubling time of these cells, the plates seeded with 15,000 cells per well would be considerably more crowded, leading to a decrease in proliferation. From previous studies, it has been shown that curcumin inhibited expression of proteins linked to proliferation, such as cyclin D1 [11] . It is possible that the compounds in the oil fraction are behaving in a similar manner or are targeting other components necessary for cell division. Results from the serum experiments indicate that the compounds in the oil fraction are interacting with proteins found in FBS, since a reduction in serum concentration correlated with an increase in potency of TO fraction, CF-3. Each three-fold reduction in the serum concentration resulted in about a two-fold increase in the potency. Low aqueous solubility of curcumin is one factor that lends to its poor bioavailability. The bioavailability of ar-turmerone, α-and β-turmerone, and curlone were shown to be 13%, 11%, and 7% [12] . More bioavailability studies in animal models need to be undertaken to evaluate the therapeutic potential of compounds found in TO. In previous studies, ar-turmerone and α-turmerone have been shown to induce apoptosis via depolarization of the mitochondrial membrane and activation of a caspase cascade [13a-13c] . CF-4, which we identified to be pure ar-turmerone, exhibited very low cytotoxic potency in the PANC-1 model used here. Furthermore, we did not see a strong reduction in the cytotoxicity of the oil fractions after the addition of Z-VAD-FMK (Figure 4 ), suggesting that the TO compounds are acting in a largely caspaseindependent mechanism in inducing cell death. Further studies will be needed to determine the mode of cell death, for example apoptosis or necrosis, and the biochemical mechanisms involved.
In conclusion, this study demonstrated that three isolated fractions of turmeric oil showed significant biological activity, comparable with that of curcumin, against the PANC-1 pancreatic cancer cell line. The fractionated components were more potent than turmeric oil itself, indicating enrichment of the active components. The compounds in these TO fractions acted in a largely caspaseindependent manner in inducing cell death. This study also demonstrates serum binding, a characteristic that will affect the pharmacokinetic behavior and potency of the compounds in vivo, and a preliminary indication of the structure-activity relationships of these compounds. In addition to the PANC-1 cells used here, CF-2 and CF-3 are also effective against the MIA PaCa 2 and L3.6 pancreatic cancer cell lines (data not shown). This suggests that the TO components may have wide utility against pancreatic cancers, warranting further investigation and development as potential therapeutic agents.
Experimental

Separation and characterization of turmeric oil fractions:
Turmeric powder (500 g) was extracted with n-hexane and the solvent was removed to obtain 27.8 g of crude extract. This was distilled under high vacuum to obtain a fraction (14.5 g) that distilled at 108-122 o C. This was further purified by silica gel CC using a step gradient of n-hexane (100 to 95%, v/v) and ethyl acetate (0 to 5%, v/v). This gave several column fractions and the following were selected for the current study: CF-1 (1.3 g), CF-2 (0.1 g), CF-3 (4.1 g), and CF-4 (0.6 g). CF-1 (0.5 g) was further purified by silica gel CC eluting with n-hexane to give 0.3 g of CF-5. HPLC and mass spectral studies of these compounds indicated that they were sesquiterpenes.
Chemicals:
The fractions of TO used in this study were obtained from turmeric powder as described above. Stock solutions of TO were prepared in dimethyl sulfoxide (DMSO) to 18.4 mg/mL (the equivalent of 50 mM curcumin for reference) and stored at -20°C until use. Dulbecco's Modified Eagle Medium (DMEM) and penicillin-streptomycin were purchased from Sigma. L-glutamine (200 mM) and trypsin-EDTA (0.25%) were purchased from Gibco. Fetal bovine serum (FBS) was purchased from Atlanta Biologicals and Z-VAD-FMK (carbobenzoxy-valyl-alanyl-aspartyl-[O-methyl] fluoromethyl ketone) from CalBioChem (Cat# 627610).
Cell culture: PANC-1 cells were obtained from the American Type Culture Collection (ATCC) and cultured in DMEM medium, containing 10% FBS, 2 mM L-glutamine, 100 units/mL penicillin and 100 µg/mL streptomycin, and maintained in a humidified incubator at 37°C in an atmosphere of 5%, v/v, CO 2 . Dilutions of DMSO stock solutions of column fractions (CF) obtained from chemical purifications were made with culture medium. The final concentration of DMSO in all experiments did not exceed 0.6%, v/v, a concentration that induced an average of 2% cell death in the PANC-1 cells. PANC-1 cells were passaged by harvesting in 2.5 mM EDTA/calcium-magnesium-free DPBS solution for 5 min.
Cytotoxicity assay: PANC-1 cells were plated in clear 96-wellplates at 5,000 cells per well, unless specified otherwise. After 24 h to allow attachment, cells were treated with the designated column fraction (CF) for 24 h. A solution of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT reagent, 10µL, Trevigen) was added to each well and the cells placed back in the incubator at 37°C with 5%, v/v, CO 2 for 3 h. Sodium dodecyl sulfate (SDS) prepared in dilute HCl was used to dissolve the resulting formazan salt into a colored solution and cells were incubated at 37°C with 5% CO 2 for another 3 h. Absorbance at 570 nm was then measured using a Victor V 1420 Multilabel Plate Reader (Perkin Elmer). For dose curves, the Effective Concentration at 50% (EC 50 ) was determined using the sigmoidal dose-response (variable slope) curve fitting algorithm of the computer program GraphPad Prism 5.04. Values are ± Standard Error of the Mean (SEM) from 3 independent experiments, each performed in 5 replicate wells. cell death using the column fractions. The MTT cytotoxicity assay was performed 24 h following the drug treatment.
Caspase inhibition assay
Supplementary data: See supplemental information for more detailed materials and methods and spectroscopic details such as GC-MS, mass spectral fragmentation, 1 H NMR, HSQC and TOCSY spectra.
